These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Increased basal ganglia binding of Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757 [TBL] [Abstract][Full Text] [Related]
44. Abnormal metabolic networks in atypical parkinsonism. Eckert T; Tang C; Ma Y; Brown N; Lin T; Frucht S; Feigin A; Eidelberg D Mov Disord; 2008 Apr; 23(5):727-33. PubMed ID: 18186116 [TBL] [Abstract][Full Text] [Related]
45. Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy. Lin WY; Lin KJ; Weng YH; Yen TC; Shen LH; Liao MH; Lu CS Nucl Med Commun; 2010 Nov; 31(11):974-80. PubMed ID: 20717064 [TBL] [Abstract][Full Text] [Related]
46. Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses. Park HK; Kim JS; Im KC; Oh SJ; Kim MJ; Lee JH; Chung SJ; Lee MC Mov Disord; 2009 Jan; 24(2):237-45. PubMed ID: 18951539 [TBL] [Abstract][Full Text] [Related]
47. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism. Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601 [TBL] [Abstract][Full Text] [Related]
48. A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study. Quattrone A; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Morelli M; Nigro S; Vescio B; Bianco MG; Vasta R; Arcuri PP; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A Mov Disord; 2021 Mar; 36(3):681-689. PubMed ID: 33151015 [TBL] [Abstract][Full Text] [Related]
49. Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease. Burciu RG; Ofori E; Shukla P; Planetta PJ; Snyder AF; Li H; Hass CJ; Okun MS; McFarland NR; Vaillancourt DE Mov Disord; 2015 Aug; 30(9):1248-58. PubMed ID: 26148135 [TBL] [Abstract][Full Text] [Related]
51. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease. Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055 [TBL] [Abstract][Full Text] [Related]
52. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease? Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107 [TBL] [Abstract][Full Text] [Related]
53. FDG PET in the differential diagnosis of parkinsonian disorders. Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501 [TBL] [Abstract][Full Text] [Related]
54. Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy. Surova Y; Nilsson M; Lätt J; Lampinen B; Lindberg O; Hall S; Widner H; Nilsson C; van Westen D; Hansson O Neuroradiology; 2015 Nov; 57(11):1079-91. PubMed ID: 26253801 [TBL] [Abstract][Full Text] [Related]
55. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445 [TBL] [Abstract][Full Text] [Related]
56. Midbrain morphology in idiopathic normal pressure hydrocephalus: A progressive supranuclear palsy mimic. Constantinides VC; Paraskevas GP; Velonakis G; Toulas P; Stefanis L; Kapaki E Acta Neurol Scand; 2020 Apr; 141(4):328-334. PubMed ID: 31856297 [TBL] [Abstract][Full Text] [Related]
57. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample. Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687 [TBL] [Abstract][Full Text] [Related]
58. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome. Picillo M; Tepedino MF; Abate F; Ponticorvo S; Erro R; Cuoco S; Oksuz N; Di Salle G; Di Salle F; Esposito F; Pellecchia MT; Manara R; Barone P Neurol Sci; 2022 Jun; 43(6):3677-3682. PubMed ID: 35106692 [TBL] [Abstract][Full Text] [Related]
59. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study. Agosta F; Kostić VS; Galantucci S; Mesaros S; Svetel M; Pagani E; Stefanova E; Filippi M Eur J Neurosci; 2010 Aug; 32(4):640-7. PubMed ID: 20597976 [TBL] [Abstract][Full Text] [Related]
60. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy. Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]